The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sofia, Bulgaria, June 23, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 22, 2020 the Company sold 25 000 own shares representing 0.0185% of the share capital of the Company, at a total value of BGN 78 750 on the Bulgarian Stock Exchange, the average price per share was 3.1500 BGN.
The total number of treasury shares after this transaction is 9 058 467, representing 6.720% of the share capital of the Company.
Sofia, Bulgaria, June 22, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 19, 2020 the Company sold 6 000 own shares representing 0.0045% of the share capital of the Company, at a total value of BGN 18 870 on the Bulgarian Stock Exchange, the average price per share was 3.1450 BGN.
The total number of treasury shares after this transaction is 9 083 467, representing 6.739% of the share capital of the Company.
Sofia, Bulgaria, June 19, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 18, 2020 the Company sold 4 000 own shares representing 0.0030% of the share capital of the Company, at a total value of BGN 12 540 on the Bulgarian Stock Exchange, the average price per share was 3.1350 BGN.
The total number of treasury shares after this transaction is 9 089 467, representing 6.743% of the share capital of the Company.
Sofia, Bulgaria, June 19, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 17, 2020 the Company sold 21 000 own shares representing 0.0156% of the share capital of the Company, at a total value of 68 030 BGN on the Bulgarian Stock Exchange, the average price per share was 3.2395 BGN.
The total number of treasury shares after this transaction is 9 093 467, representing 6.746% of the share capital of the Company